Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Matilda Florentin"'
Autor:
Petros Spyridonas Adamidis, Matilda Florentin, Evangelos Liberopoulos, Amalia Despoina Koutsogianni, Georgia Anastasiou, George Liamis, Haralampos Milionis, Fotios Barkas
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 2, p 60 (2024)
Background and Aim: Serum alkaline phosphatase (ALP) activity has been associated with atherosclerotic cardiovascular disease (ASCVD). We aimed to investigate the association of ALP with ASCVD in patients with dyslipidemia. Methods: We conducted a re
Externí odkaz:
https://doaj.org/article/e2a9bf50596c4c0c8bfe4a619eb55865
Autor:
Amalia Despoina Koutsogianni, George Liamis, Evangelos Liberopoulos, Petros Spyridonas Adamidis, Matilda Florentin
Publikováno v:
Pharmaceuticals, Vol 16, Iss 5, p 750 (2023)
The past few years have shown an ongoing interest in lipoprotein(a) (Lp(a)), a lipid molecule that has been proven to have atherogenic, thrombogenic, and inflammatory properties. Several lines of evidence, indeed, have demonstrated an increased risk
Externí odkaz:
https://doaj.org/article/270468f257564de986350a0e482011cc
Autor:
Christos V. Rizos, Matilda Florentin, Ioannis Skoumas, Konstantinos Tziomalos, Loukianos Rallidis, Vasileios Kotsis, Vasileios Athyros, Emmanouil Skalidis, Genovefa Kolovou, Anastasia Garoufi, Eleni Bilianou, Iosif Koutagiar, Dimitrios Agapakis, Estela Kiouri, Christina Antza, Niki Katsiki, Evangelos Zacharis, Achilleas Attilakos, George Sfikas, Panagiotis Anagnostis, Demosthenes B. Panagiotakos, Evangelos N. Liberopoulos
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-13 (2020)
Abstract Background Familial hypercholesterolemia (FH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease (CVD) risk. FH patients often have increased lipoprotein(a) [Lp(a)] levels, wh
Externí odkaz:
https://doaj.org/article/aecf23dc5acf458896d849d0d3514472
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract Magnesium (Mg) is commonly addressed as the “forgotten ion” in medicine. Nonetheless, hypomagnesemia should be suspected in clinical practice in patients with relevant symptomatology and also be considered a predisposing factor for the d
Externí odkaz:
https://doaj.org/article/0b47641253624afa903b8a30afb27838
Autor:
Christina E. Kostara, Kiriaki S. Karakitsou, Matilda Florentin, Eleni T. Bairaktari, Vasilis Tsimihodimos
Publikováno v:
Metabolites, Vol 12, Iss 8, p 683 (2022)
Prediabetes is a clinically silent, insulin-resistant state with increased risk for the development of type 2 diabetes (T2D) and cardiovascular disease (CVD). Since glucose homeostasis and lipid metabolism are highly intersected and interrelated, an
Externí odkaz:
https://doaj.org/article/1fa37be8517e4b35bf971c35592be271
Publikováno v:
European Journal of Case Reports in Internal Medicine (2020)
Hyperemesis gravidarum (HG) is a complication mainly of the first trimester of pregnancy, which sometimes leads to metabolic disorders such as hypovolemia and acute kidney injury (AKI). Herein, we present the case of a 25-year-old woman at week 10 of
Externí odkaz:
https://doaj.org/article/21b511440bc547369d11759e86da94f7
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 2, p 42 (2022)
Hypertriglyceridemia has been identified as a risk factor for cardiovascular disease and acute pancreatitis. To date, there are only few drug classes targeting triglyceride levels such as fibrates and ω-3 fatty acids. These agents are at times insuf
Externí odkaz:
https://doaj.org/article/e9b865b8d83c47ae93098b38c8c70053
Publikováno v:
Journal of Atherosclerosis Prevention and Treatment. 12:84-91
The relationship of dyslipidemia with atrial fibrillation (AF)-related stroke is not clear. The question whether patients with AF-related stroke should receive lipid lowering agents unanimously remains unanswered. Treatment with statins does not appe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1da13b76c609fcc025d2faad1a78a5ad
https://doi.org/10.53590/japt.02.1027
https://doi.org/10.53590/japt.02.1027
Autor:
Matina Kouvari, Evangelia Damigou, Matilda Florentin, Rena I. Kosti, Christina Chrysohoou, Christos S. Pitsavos, Demosthenes B. Panagiotakos
Publikováno v:
Nutrients; Volume 14; Issue 24; Pages: 5291
Purpose: To examine the association of egg intake with 10-year risk of cardiovascular disease (CVD) and other cardiometabolic risk factors in a sample of individuals of Mediterranean origin. Methods: In 2001–2002, n = 1514 men and n = 1528 women (>
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7122294e7d018558e9b0e7ec61dfc5d1
https://pubmed.ncbi.nlm.nih.gov/36558450
https://pubmed.ncbi.nlm.nih.gov/36558450
Publikováno v:
European Journal of Preventive Cardiology. 29:739-755
Advances in several fields of cardiovascular (CV) medicine have produced new treatments (e.g. to treat dyslipidaemia) that have proven efficacy in terms of reducing deaths and providing a better quality of life. However, the burden of CV disease (CVD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe120b3fa1e2ac7c753bef79e6b835e
https://doi.org/10.1093/eurjpc/zwab052
https://doi.org/10.1093/eurjpc/zwab052